# Our Customers | Pharma & Biotech Partners | IXICO IXICO partners with leading pharmaceutical and biotech companies worldwide. Discover how we support CNS clinical trials with neuroimaging expertise and analytics. # Our Customers At IXICO, we work closely with our customers to deliver precision imaging solutions that accelerate the development of treatments for neurological diseases. We support every stage of neurological  clinical trials—from early feasibility to post-marketing surveillance. ## Who We Work With ### Global biopharmaceutical companies Developing novel therapies for Alzheimer’s, Huntington’s, Parkinson’s, and other neurodegenerative diseases, seeking agile, scalable imaging solutions for clinical trials. ### Academic research institutions Conducting foundational neuroscience studies. ### Disease-focused charities and consortiums Advancing inclusive and patient-centric research. ## Meeting Specific Client Needs ## Clinical Operations Leads ![icons navy 09](/assets/element-images/icons-navy-09__FitMaxWzk2MCw1NDBd_ExtRewriteWyJwbmciLCJ3ZWJwIl0.webp "icons navy 09") **Driving global clinical trial imaging execution with confidence** Clinical Operations professionals are responsible for planning, executing, and overseeing clinical trials. They manage timelines, budgets, site performance, and vendor coordination to ensure trials run smoothly and meet regulatory standards. **How IXICO supports them:** - **Operational Efficiency:** The IXI**™** Platform streamlines imaging workflows—from site qualification to scan upload and quality control—reducing delays and manual oversight. - **Global Site Enablement:** With a network of over 2,000 imaging centres and a global site support system, we help Clinical Ops teams activate sites quickly and maintain high-quality data collection across geographies. - **Real-Time Oversight:** Our dashboards and reporting tools provide visibility into scan status, site performance, and protocol compliance—empowering proactive decision-making. Our operations team acts as an extension of theirs—responsive, reliable, and deeply experienced in navigating the complexities of imaging operations for global CNS trials. ## Scientific Leads & Medical Directors ![icons navy 05](/assets/element-images/icons-navy-05__FitMaxWzk2MCw1NDBd_ExtRewriteWyJwbmciLCJ3ZWJwIl0.webp "icons navy 05") **Translating imaging science into clinical impact** Scientific Leads, including Medical Directors and Translational Scientists, are focused on the scientific integrity of the trial. They define imaging endpoints, select imaging biomarkers, and interpret data to assess therapeutic efficacy and disease progression. **How IXICO supports them:** - **Biomarker Strategy:** We collaborate early to define imaging endpoints that align with the therapeutic mechanism and regulatory expectations. - **Advanced Imaging Analytics:** The IXI**™** Platform delivers quantitative analysis, enabling sensitive detection of treatment effects and disease progression. - **Regulatory Confidence:** Our validated methodologies and audit-ready data packages support submissions to global regulatory bodies, including the FDA and EMA. Our scientific team works closely with theirs, ensuring that imaging data is not only collected but also transformed into actionable insights that drive smarter decisions. ## Let’s Talk About Your Next Trial Whether you're planning a Phase 1 study or scaling up for a global Phase 3, IXICO is ready to support your journey. Contact us today to explore how our AI-driven imaging expertise can accelerate your clinical development. [ Get in Touch with Our Neuroimaging Experts ](/contact-us/)